High antiviral activity of NS5A inhibitor ABT‐530 with paritaprevir/ritonavir and ribavirin against hepatitis C virus genotype 3 infection

Por Poordad, Fred, Landis, Charles S., Asatryan, Armen, Jackson, Daniel F., Ng, Teresa I., Fu, Bo, Lin, Chih‐Wei, Yao, Betty, Kort, Jens
Publicado no Liver Int (2016)

Selection and Characterization of Varicella-Zoster Virus Variants Resistant to (R)-9-[4-Hydroxy-2-(Hydroxymethy)Butyl]Guanine

Por Ng, Teresa I., Shi, Yan, Huffaker, H. Janette, Kati, Warren, Liu, Yaya, Chen, Chih-Ming, Lin, Zhen, Maring, Clarence, Kohlbrenner, William E., Molla, Akhteruzzaman
Publicado em 2001

Characterization of a Novel Human Immunodeficiency Virus Type 1 Protease Inhibitor, A-790742

Por Dekhtyar, Tatyana, Ng, Teresa I., Lu, Liangjun, Masse, Sherie, DeGoey, David A., Flosi, William J., Grampovnik, David J., Klein, Larry L., Kempf, Dale J., Molla, Akhteruzzaman
Publicado em 2008

In Vitro Selection and Characterization of Influenza A (A/N9) Virus Variants Resistant to a Novel Neuraminidase Inhibitor, A-315675

Por Molla, Akhteruzzaman, Kati, Warren, Carrick, Robert, Steffy, Kevin, Shi, Yan, Montgomery, Debra, Gusick, Nanette, Stoll, Vincent S., Stewart, Kent D., Ng, Teresa I., Maring, Clarence, Kempf, Dale J., Kohlbrenner, William
Publicado em 2002

Emergence of ON1 genotype of human respiratory syncytial virus subgroup A in China between 2011 and 2015

Por Song, Jinhua, Zhang, Yan, Wang, Huiling, Shi, Jing, Sun, Liwei, Zhang, Xiaojie, Yang, Zifeng, Guan, Wenda, Zhang, Hong, Yu, Pengbo, Xie, Zhengde, Cui, Aili, Ng, Teresa I., Xu, Wenbo
Publicado no Sci Rep (2017)

Acyclovir Is Phosphorylated by the Human Cytomegalovirus UL97 Protein

Por Talarico, Christine L., Burnette, Thimysta C., Miller, Wayne H., Smith, Sheila L., Davis, Michelle G., Stanat, Sylvia C., Ng, Teresa I., He, Zuwen, Coen, Donald M., Roizman, Bernard, Biron, Karen K.
Publicado em 1999

Emergence of BA9 genotype of human respiratory syncytial virus subgroup B in China from 2006 to 2014

Por Song, Jinhua, Wang, Huiling, Shi, Jing, Cui, Aili, Huang, Yanzhi, Sun, Liwei, Xiang, Xingyu, Ma, Chaofeng, Yu, Pengbo, Yang, Zifeng, Li, Qi, Ng, Teresa I., Zhang, Yan, Zhang, Rongbo, Xu, Wenbo
Publicado no Sci Rep (2017)

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS5A Inhibitor Pibrentasvir

Por Ng, Teresa I., Krishnan, Preethi, Pilot-Matias, Tami, Kati, Warren, Schnell, Gretja, Beyer, Jill, Reisch, Thomas, Lu, Liangjun, Dekhtyar, Tatyana, Irvin, Michelle, Tripathi, Rakesh, Maring, Clarence, Randolph, John T., Wagner, Rolf, Collins, Christine
Publicado no Antimicrob Agents Chemother (2017)

Potent Antiviral Activities of the Direct-Acting Antivirals ABT-493 and ABT-530 with Three-Day Monotherapy for Hepatitis C Virus Genotype 1 Infection

Por Lawitz, Eric J., O'Riordan, William D., Asatryan, Armen, Freilich, Bradley L., Box, Terry D., Overcash, J. Scott, Lovell, Sandra, Ng, Teresa I., Liu, Wei, Campbell, Andrew, Lin, Chih-Wei, Yao, Betty, Kort, Jens
Publicado no Antimicrob Agents Chemother (2016)

Glecaprevir and pibrentasvir for 12 weeks for hepatitis C virus genotype 1 infection and prior direct‐acting antiviral treatment

Por Poordad, Fred, Felizarta, Franco, Asatryan, Armen, Sulkowski, Mark S., Reindollar, Robert W., Landis, Charles S., Gordon, Stuart C., Flamm, Steven L., Fried, Michael W., Bernstein, David E., Lin, Chih‐Wei, Liu, Ran, Lovell, Sandra S., Ng, Teresa I., Kort, Jens, Mensa, Federico J.
Publicado no Hepatology (2017)

In Vitro Antiviral Activity and Resistance Profile of the Next-Generation Hepatitis C Virus NS3/4A Protease Inhibitor Glecaprevir

Por Ng, Teresa I., Tripathi, Rakesh, Reisch, Thomas, Lu, Liangjun, Middleton, Timothy, Hopkins, Todd A., Pithawalla, Ron, Irvin, Michelle, Dekhtyar, Tatyana, Krishnan, Preethi, Schnell, Gretja, Beyer, Jill, McDaniel, Keith F., Ma, Jun, Wang, Guoqiang, Jiang, Li-Juan, Or, Yat Sun, Kempf, Dale, Pilot-Matias, Tami, Collins, Christine
Publicado no Antimicrob Agents Chemother (2017)

Glecaprevir/Pibrentasvir in patients with hepatitis C virus genotype 1 or 4 and past direct‐acting antiviral treatment failure

Por Poordad, Fred, Pol, Stanislas, Asatryan, Armen, Buti, Maria, Shaw, David, Hézode, Christophe, Felizarta, Franco, Reindollar, Robert W., Gordon, Stuart C., Pianko, Stephen, Fried, Michael W., Bernstein, David E., Gallant, Joel, Lin, Chih‐Wei, Lei, Yang, Ng, Teresa I., Krishnan, Preethi, Kopecky‐Bromberg, Sarah, Kort, Jens, Mensa, Federico J.
Publicado no Hepatology (2018)